Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001628280-23-022732

Options or other derivatives

  • Director acquired 27,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mohindru Mani Director 2023-06-15 Grant or award · Stock Options +27,700 98,501 D
Loading xslF345X04/wk-form4_1687294992.xml…